![]() |
|
|
Vol. 294, Issue 2, 753-761, August 2000
-Lyase/Glutamine Transaminase
K1
Leiden/Amsterdam Center for Drug Research, Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
| |
Abstract |
|---|
|
|
|---|
Selenocysteine Se-conjugates have recently been proposed as
potential prodrugs to target pharmacologically active selenol compounds
to the kidney. Although rat renal cytosol displayed a high activity of
-elimination activity toward these substrates, the enzymes involved
in this activation pathway as yet have not been identified. In the
present study, the possible involvement of cysteine conjugate
-lyase/glutamine transaminase K (
-lyase/GTK) in cytosolic
activity was investigated. To this end, the enzyme kinetics of 15 differentially substituted selenocysteine Se-conjugates and 11 cysteine
S-conjugates was determined using highly purified rat
renal
-lyase/GTK. The results demonstrate that most selenocysteine Se-conjugates are
-eliminated at a very high activity by purified
-lyase/GTK, implicating an important role of this protein in the
previously reported
-elimination reactions in rat renal cytosol. As
indicated by the rapid consumption of
-keto-
-methiolbutyric acid,
purified
-lyase/GTK also catalyzed transamination reactions, which
appeared to even exceed that of
-elimination. The corresponding sulfur analogs also showed significant transamination but were
-eliminated at an extremely low rate. Comparison of the obtained enzyme kinetic data of purified
-lyase/GTK with previously obtained data from rat renal cytosol showed a poor correlation. By determining the activity profiles of cytosolic fractions applied to anion exchange
fast protein liquid chromatography and gel filtration chromatography,
the involvement of multiple enzymes in the
-elimination of
selenocysteine Se-conjugates in rat renal cytosol was demonstrated. The
identity and characteristics of these alternative selenocysteine conjugate
-lyases, however, remain to be established.
| |
Introduction |
|---|
|
|
|---|
The
conjugation of electrophilic substrates to glutathione (GSH) and
subsequent disposition of the GSH S-conjugates formed are
mediated by a large number of different enzymes and transport systems
present in various tissues (Commandeur et al., 1995
). One of the
pathways involved in the catabolism of GSH-conjugates is the
-elimination reaction of the corresponding cysteine
S-conjugates by cysteine conjugate
-lyases (
-lyases),
resulting in the formation of ammonia, pyruvic acid, and thiol
compounds. In the case of glutathione S-conjugates of
halogenated alkenes, the thiols formed by
-lyase may rearrange
rapidly to chemically highly reactive intermediates, such as thionoacyl
halides, thiiranes, and/or thioketenes (Dekant et al., 1988
; Commandeur
et al., 1996
). The combination of active uptake mechanisms and a
relatively high activity of
-lyase in the kidney may explain the
relatively selective nephrotoxicity of many halogenated alkenes in
rodents. A number of studies by the group of Elfarra have demonstrated
that the biochemical basis of this kidney selectivity may also be
applied to target pharmacologically active thiol-containing antitumor
agents, such as mercaptopurine and thioguanine, to the kidney for the
treatment of renal cell carcinoma (Hwang and Elfarra, 1989
, 1991
;
Elfarra and Hwang, 1993
; Elfarra et al., 1995
). More recently,
the structurally strongly related selenocysteine Se-conjugates were
proposed as alternative prodrugs to target pharmacologically selenol
compounds to the kidney by local
-lyase enzyme systems (Andreadou et
al., 1996
).
Although the above-mentioned prodrugs appear to be activated by renal
subcellular fractions, the enzymes that are actually involved in these
-elimination reactions have not yet been identified. To elucidate
the possibilities and limitations of this prodrug concept, however, the
identity and tissue distribution of the enzymes involved in the
activation of cysteine S-conjugates and selenocysteine
Se-conjugates remain to be characterized.
Three major cysteine conjugate
-lyase enzymes have
been identified in rat kidney cytosol (Cooper, 1998
). All are pyridoxal 5'-phosphate-dependent enzymes. One cytosolic
-lyase in the kidney appeared to be identical with glutamine transaminase K (GTK), based on
its composition and enzyme kinetic properties (Stevens et al., 1986
).
Originally denoted as GTK, this enzyme was isolated more than 25 years
ago (Cooper and Meister, 1974
).
-Lyase/GTK is a dimeric protein
consisting of two identical subunits of
Mr 47,470. Recent cloning studies
revealed that
-lyase/GTK is also identical with kynurenine
aminotransferase (Perry et al., 1993
; Mosca et al., 1994
). More
recently, a closely related cysteine conjugate
-lyase, with subunits
of a slightly higher3 molecular weight, 48,500, was characterized with considerable overlap in substrate selectivity
(Abraham and Cooper, 1996
). Finally, a
-lyase enzyme with high
molecular weight (330,000) was demonstrated to be present in both
cytosolic and mitochondrial fractions. This third
-lyase has
different enzyme characteristics compared with
-lyase/GTK as
demonstrated by its ability to convert leukotriene E4 and 5'-S-cysteinyldopamine and by
its lower specific activity toward cysteine conjugates of halogenated
alkenes (Abraham et al., 1995
).
Recently, we demonstrated that replacing the sulfur of cysteine
S-conjugates by a selenium atom resulted in a dramatic
increase in
-elimination activity in rat renal cytosol (Andreadou et
al., 1996
). Therefore, selenocysteine Se-conjugates were proposed as alternative prodrugs to target pharmacologically active selenol compounds to the kidney (Fig. 1). The aim
of the present investigation was to study whether selenocysteine
Se-conjugates are substrates for purified rat renal
-lyase/GTK. Next
to the selenocysteine Se-conjugates, a number of corresponding cysteine
S-conjugates were tested as substrates for purified rat
renal
-lyase/GTK as well. Because the enzyme kinetics obtained with
the purified enzyme showed a relatively poor correlation with results
previously obtained with rat renal cytosol, the possible involvement of
multiple enzymes was studied by determining the activity profiles after
fractionation of rat renal cytosol by two different chromatographic
methods: anion exchange chromatography and gel permeation
chromatography.
|
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
-Keto-
-methiolbutyric acid (KMB),
-chloro-L-alanine,
S-methyl-L-cysteine,
S-ethyl-L-cysteine,
S-benzyl-L-cysteine, and a diagnostic
kit for aspartate aminotransferase (DG158-K) were purchased from Sigma
Chemical Co. (St. Louis, MO). Amino-oxyacetic acid and
phenylmethylsulfonyl fluoride (PMSF) were obtained from Aldrich Chemie
(Brussels, Belgium). 4-Methoxythiophenol was obtained from Fluka
(Buchs, Switzerland).
S-(4-Methylbenzyl)-L-cysteine was
purchased from Advanced Chemtech (Louisville, KY).
S-(4-Methoxybenzyl)-L-cysteine was
purchased from Bachem Feinchemikalien AG (Bubendorf, Switzerland).
Synthesis of Se-Allyl-L-selenocysteine.
L-Selenocystine (1.5 mmol, 500 mg) was dissolved in 8 ml of
0.5 N NaOH and 2 ml of ethanol. At 0°C, 0.4 g (15 mmol) of
NaBH4 was added while the reaction mixture was
stirred. The mixture was allowed to reach room temperature, during
which the color of the solution changed from yellow to colorless, After
cooling again to 0°C, 4 ml of 2 N NaOH and 6 mmol of allylbromide
were added, and the mixture was stirred for 3 h at room
temperature. Concentrated HCl was added until pH 5 to 6 and cooled at
4°C. Se-Allyl-L-cysteine precipitated as a yellowish
solid. The 1H NMR spectrum obtained was almost
identical with that of
S-allyl-L-cysteine (17):
1H NMR (D2O,
Na2CO3):
(ppm) 2.95 to
3.22 (2H, m,
CH2-CH-NH2), 3.30 (2H, d,
CH2==CH-CH2),
4.25 to 4.40 (1H, d of d,
CH2-CH-NH2), 5.05 to 5.25 (2H, m,
CH2==CH-CH2),
5.80 to 6.08 (1H, m,
CH2==CH-CH2).
Purification of Rat Renal Cysteine Conjugate
-Lyase/GTK.
-Lyase/GTK was purified from rat renal cytosol obtained from male
Wistar rats (160-250 g) supplied by Harlan (Zeist, the Netherlands).
The procedure used is described in detail by Yamauchi et al. (1993)
and
yielded a highly purified enzyme that was 1000-fold enriched according
to its increased specific activity with
S-(1,2-dichlorovinyl)-L-cysteine (1,2-DCV-Cys) as a substrate. Matrix-assisted laser desorption time-of-flight (MALDI-TOF) mass spectrometry analysis of this protein
revealed a single MH+ mass of
Mr 47,700 ± 130,4 which is consistent with the mass as
predicted from the sequence of
-lyase/GTK as determined by Perry et
al. (1993)
.
-lyase/GTK obtained was dissolved in 50 mM Tris-HCl
buffer, pH 8.0, and was stored in 100-µl fractions of 100 µg/ml at
20°C. When stored under these conditions, no significant decrease
in specific activity toward 1,2-DCV-Cys was observed after 2 years.
Enzymatic Incubations.
Selenocysteine Se-conjugates and
cysteine S-conjugates were incubated with the purified
-lyase in 50 mM Tris-HCl buffer, pH 8.6, and at a temperature of
37°C. Unless stated otherwise, the final concentration of enzyme was
1 µg/ml. The cofactor KMB was added at a final concentration of 0.2 mM, which allows assessment of transamination reaction by measuring KMB
consumption (see later). After 2 min of preincubation at 37°C,
incubations were started by the addition of a 10-fold concentrated
enzyme solution.
-Elimination reactions were assessed by determining
the formation of pyruvic acid. To correct for background production of
pyruvic acid, parallel incubations were always performed in absence of
enzyme. All incubations were always performed in duplicate.
-keto acid cofactor KMB
as described previously (Cooper and Meister, 1974
-keto acid products formed from
the conjugates studied. Both pyruvic acid and KMB can be assessed in a
single assay after derivatization with the
-keto acid-reagent
o-phenylene diamine (OPD), followed by analysis by HPLC
equipped with fluorescence detection (Stijntjes et al., 1992
-lyase/GTK (final concentration). To obtain
significant KMB consumption with cysteine S-conjugates, these compounds were incubated for 30 min at 37°C in presence of 2 µg/ml
-lyase/GTK.
Time Course of Enzyme Reactions.
Before determining enzyme
kinetics, the time course of product formation was determined to assess
the linearity of the
-elimination reactions. To this end,
incubations were performed at an incubation volume of 2 ml. After
starting the reaction by the addition of 200 µl of 10 µg/ml enzyme
solution, samples of 100 µl were taken from the incubation at several
time points and mixed with 500 µl of OPD solution (12 mM OPD in 3 M
HCl) in 1-ml Eppendorf cups. The Eppendorf cups were closed and heated
for 60 min at 60°C to complete the derivatization reaction (Stijntjes
et al., 1992
). To the resulting solutions, 600 µl of HPLC eluent
(45% methanol, 54% water, 1% acetic acid) was added and transferred
to HPLC vials for automated HPLC analysis (see later).
Enzyme Kinetic Parameters.
Enzyme kinetic parameters
(Km and
kcat) of conjugates were determined by
incubating substrates at six to eight concentrations ranging from 0.05 to 4 mM. Due to their poor solubility, the conjugates with phenyl and
benzyl substituents were incubated at concentrations up to 2 mM.
Corrections for nonenzymatic degradation were made by performing
parallel incubations in absence of enzyme. All incubations were
performed at 37°C and at a total volume of 300 µl and were started
by adding 30 µl of 10 µg/ml purified
-lyase/GTK. The final
concentration of KMB in all incubations was 0.2 mM. Reactions were
stopped after 5 min of incubation by the addition of 1 ml of 12 mM OPD
in 3 M HCl. The resulting mixtures were subsequently heated for 60 min
at 60°C. After this derivatization reaction, a volume of 600 µl was
mixed with 600 µl of HPLC eluent (45% methanol, 54% water, 1%
acetic acid) and transferred to HPLC vials for automated HPLC analysis
(see later).
HPLC Analysis of Pyruvic Acid and KMB. HPLC vials were placed in a Waters 707 Autoinjector cooled at 4°C. Then, 100-µl samples were injected at intervals of 20 min. The analytes were chromatographed on two ChromSpher C18 columns (5-µm particles, 100 × 4.6 mm; Chrompack, Bergen op Zoom, The Netherlands), which was eluted isocratically with the above-mentioned HPLC eluent at a flow rate of 0.4 ml/min. Detection of derivatized pyruvic acid and KMB was accomplished with a Jasco fluorescence detector (model 821-FP) set at an excitation wavelength of 336 nm and an emission wavelength of 420 nm. Chromatograms were analyzed using the Class VP 4.1 software package of Shimadzu (Columbia, MD). Under these conditions, retention times of derivatized pyruvic acid and KMB were 5.8 and 14.9 min, respectively.
For quantification of the analytes, calibration curves were constructed by derivatizing known concentrations (ranging from 5 to 200 µM) of pyruvic acid and KMB in 50 mM Tris-HCl, pH 8.6, with 12 mM OPD in 3 M HCl. After heating for 60 min at 60°C, samples were treated and analyzed in the same manner as described above.Fractionation of Rat Kidney Cytosol by Anion Exchange Fast Protein Liquid Chromatography (FPLC). Rat kidney cytosol was fractionated by FPLC using a Mono-Q anion exchange column (Pharmacia Biotech, Uppsala, Sweden). Before application to the column, rat kidney cytosol was dialysed for 20 h against 20 mM triethanol-HCl buffer, pH 7.45, containing 0.1 mM EDTA and 40 µM PMSF (buffer A). After dialysis, this enzyme fraction was filtered using a 0.2-µm Schlauer filter, and 0.5 ml (containing 19 mg of cytosolic protein) was applied to the Mono-Q column, which was equilibrated with the same buffer as used for dialysis.
The column was eluted at a flow rate of 1 ml/min. After an initial 10 min of elution with buffer A, a linear gradient was started by mixing with buffer B (buffer A containing 900 mM sodium chloride). Fifty minutes after the start of the gradient, the eluent reached 100% buffer B. During chromatography, elution of proteins was monitored by UV detection at 280 nm. From the start of the FPLC, 40 fractions of 2 ml were collected and stored at
20°C until analysis for enzyme activity.
Activity profiles of
-elimination were determined by incubating all
fractions with five different substrates: CTFE-Cys,
Se-phenyl-L-selenocysteine, Se-allyl-L-selenocysteine,
Se-isopropyl-L-selenocysteine, and Se-(4-methylbenzyl)-L-selenocysteine. Then, 15 µl of the
FPLC fractions was added to 135 µl of 50 mM Tris-HCl buffer, pH 8.6, containing 2 mM substrate and 0.2 mM KMB. Incubations were performed for 20 min at 37°C, after which the reaction was terminated by adding
500 µl of 12 mM OPD in 3 N HCl. After 60 min of derivatization at
60°C, the samples were analyzed by HPLC, as described earlier.
Elution of aspartate aminotransferase, which was previously proposed as
an alternative
-eliminating enzyme (Kato et al., 1996Fractionation of Rat Kidney Cytosol by Gel Permeation Chromatography. Rat renal cytosol (5 ml) was applied to a HiLoad 16/60 Superdex 200 column (Pharmacia Biotech) and eluted at a flow rate of 0.5 ml/min with 50 mM sodium phosphate buffer, pH 7.4, containing 150 mM sodium chloride and 40 µM PMSF. After 65 min, representing the time necessary to elute the dead volume, fractions of 0.5 ml were collected and placed on ice. Elution of proteins was monitored continuously by UV detection at 280 nm. Activities were determined using Se-(4-methylbenzyl)-L-selenocysteine and CTFE-Cys as substrates. Then, 15 µl of the fractions was added to 135 µl of 50 mM Tris-HCl buffer, pH 8.6, containing substrate and 0.5 mM KMB. Incubations were performed for 20 min at 37°C, after which the reaction was terminated by adding 500 µl of 12 mM OPD in 3 M HCl. After 60 min of derivatization at 60°C, the samples were analyzed by HPLC, as described earlier.
Retention times of gel permeation column were calibrated by eluting a mixture of marker proteins of known molecular weight. Observed retention times were
-lactalbumin (14,200 Da), 302 min; carbonic anhydrase (29,000 Da), 257 min; chicken egg albumin (45,000 Da), 188 min; BSA monomer (66,000 Da), 177 min; BSA dimer (132,000 Da),
161 min; urease trimer (272,000 Da), 146 min; and urease hexamer
(545,000 Da), 125 min.
| |
Results |
|---|
|
|
|---|
Time Course of Biotransformation of Cysteine
S-Conjugates and Selenocysteine Conjugates.
A
significant time-dependent formation of pyruvic acid was observed on
incubation of purified
-lyase/GTK with cysteine
S-conjugates of halogenated alkenes and with various
selenocysteine Se-conjugates (Fig. 2).
Because pyruvate formation significantly deviated from linearity after
approximately 5 min, the enzyme kinetic parameters Km and
kcat for the conjugates were based on
the specific activities obtained using incubation times of 5 min.
|
-lyase/GTK, which is converted to the PMP form by a
concurrent transamination-reaction route (Stevens et al., 1986Substrate Selectivity and Kinetics of Purified
-Lyase/GTK.
The specific activities and enzyme kinetic parameters of purified
-lyase/GTK toward 11 cysteine S-conjugates and 15 selenocysteine Se-conjugates as substrates are shown in Table
1. From these results, it appears that
most cysteine S-conjugates tested showed only a very low
-elimination activity. Significant consumption of KMB was observed,
indicative for a preference for the transamination reaction. The only
L-cysteine S-conjugates showing a
sufficiently high
-elimination activity enabling assessment of
enzyme kinetic parameters were the four cysteine
S-conjugates carrying halogenated alkyl and alkenyl
substituents. A decrease in specific activity and
kcat/Km
was observed in the order TFE-Cys > CTFE-Cys > DCDFE-Cys
1,2-DCV-Cys. These nephrotoxic cysteine
S-conjugates also appear to be transaminated to a
significant extent as indicated by a significant consumption of KMB
(Table 1). The relative importance of transamination appears to
slightly increase in the order TFE-Cys < CTFE-Cys < DCDFE-Cys
1,2-DCV-Cys.
|
-lyase/GTK (Table 1). The
-elimination activities of several selenocysteine Se-conjugates were almost equivalent to that of TFE-Cys, the best
-elimination substrate for
this enzyme known as yet. Furthermore, transamination appears to be an
important pathway of metabolism of selenocysteine Se-conjugates, because KMB consumption was always significantly higher than pyruvic acid production. Of three selenocysteine Se-conjugates, the
D-selenocysteine Se-conjugates were also tested:
Se-(methyl)-D-selenocysteine, Se-(n-propyl)-D-selenocysteine, and
Se-(4-methylbenzyl)-D-selenocysteine. For these
stereoisomers, however, no significant
-elimination or KMB
consumption was observed, indicative of absolute stereoselectivity of
-lyase/GTK for the L-isomers. The pyruvic acid
formation and KMB consumption of all substrates shown in Table 1 could
be blocked completely by 1 mM amino-oxyacetic acid.
The specific activities of
-elimination of selenocysteine conjugates
with n-alkyl-substituents were 30 to 50 times higher than
that of the corresponding cysteine S-conjugates, enabling Lineweaver-Burke analyses. An increase in the length of the
n-alkyl-chain appears to increase the affinity for
-lyase/GTK, because the Michaelis-Menten constant
Km decreases significantly from 5 mM (methyl substituent) to 0.26 mM (n-butyl-substituent). In
contrast, kcat values decrease with
increased chain length.
Se-(n-Butyl)-L-selenocysteine showed
substrate inhibition at concentrations higher than 0.5 mM. Therefore,
the enzyme kinetic parameters for this substrate were estimated from
the activities obtained below 0.5 mM.
Se-Allyl-L-selenocysteine and
S-allyl-L-cysteine, compounds known to
occur in garlic (Lu et al., 1996
-elimination on
incubation with purified
-lyase/GTK (Table 1). Again, the selenium
compound showed a 30-fold higher specific activity at a concentration
of 0.5 mM than its sulfur analog. For
S-allyl-L-cysteine, enzyme activities
were too low to allow determination of enzyme kinetic parameters
Km and
kcat. With
Se-allyl-L-selenocysteine as substrate, KMB
consumption was almost 4-fold higher than pyruvic acid formation, again
indicative for extensive concurrent transamination. KMB consumption was
also observed in incubations with
S-allyl-L-cysteine although at an
approximately 10-fold lower rate compared with its selenium analog.
Selenocysteine Se-conjugates with benzyl substituents also showed high
-elimination activities (Table 1). Interestingly, para-substitution at the benzyl group strongly increased
enzyme activities compared with the unsubstituted
Se-benzyl-L-selenocysteine;
-elimination
activities almost equaled those of TFE-Cys. Because KMB consumption
even exceeds pyruvic acid formation, these results suggest that overall
activity (i.e.,
-elimination plus transamination) of the substituted
Se-benzyl-L-selenocysteines is even higher than
that of TFE-Cys. No clear differences were observed between electron-withdrawing (chloro substituents) and electron-donating (methyl and methoxy substituents) substituents, suggesting that steric
or lipophilic effects are more important than electronical effects.
Se-phenyl-L-selenocysteine also is a very good substrate
for
-lyase/GTK, as indicated by its high activities of pyruvic acid production and KMB consumption. The specific activity of
Se-phenyl-L-selenocysteine at 0.5 mM is more than 150-fold
higher than that of
S-phenyl-L-cysteine (Table 1), again
pointing to the superiority of selenocysteine Se-conjugates over
cysteine S-conjugates as substrates for
-lyase/GTK. However, in contrast to the benzyl-substituted
selenocysteine-Se-conjugates, the introduction of
para-substituents at the phenyl ring of
Se-phenyl-L-selenocysteine results in a dramatic
decrease in enzyme activity (Table 1). To generate sufficient pyruvic
acid, incubation with these substrates were performed for 20 min and in
presence of a 10-fold higher concentration of purified
-lyase/GTK.
Se-(4-methylphenyl)-L-selenocysteine and
Se-(4-chlorophenyl)-L-selenocysteine demonstrated
substrate inhibition at concentrations higher than 0.5 mM.
Se-(4-methoxyphenyl)-L-selenocysteine was the
selenocysteine Se-conjugates displaying the lowest pyruvic acid
formation (Table 1).
Fractionation of Rat Kidney Cytosol by Anion Exchange
Chromatography.
Rat renal cytosol was fractionated using Mono-Q
anion exchange FPLC, and the 2-ml fractions collected were subsequently
screened for
-lyase activity using five different substrates. Using
CTFE-Cys as a substrate, the highest activity was found in fraction 10, whereas lower activities were found in fractions 11, 12, and 13 (Fig.
3A). In incubations of fractions with
CTFE-Cys as a substrate, only a relatively small consumption of KMB was
observed (<20% of the initial 0.2 mM concentration). When using
Se-phenyl-L-selenocysteine and
Se-(4-methylbenzyl)-L-selenocysteine as substrate, however, a significantly different activity profile was observed, which rules
out involvement of only a single enzyme in the
-elimination reactions. First, in contrast to CTFE-Cys, maximal activity was observed in fraction 11 (Fig. 3, B and C). Second, using these selenocysteine conjugates, very significant pyruvic acid formation was
also observed in fractions 14 to 18. Furthermore, with both substrates,
a much stronger, up to 60%, consumption of KMB was observed, which
again was significant from fractions 10 to 18. To test whether KMB
might have become limiting in these experiments, the activity of these
fractions were also determined in presence of 0.5 mM KMB.
Interestingly, at this higher KMB concentration, the highest pyruvate
formation was observed in fraction 10, as is the case with CTFE-Cys as
substrate (data not shown).
|
-lyase/GTK in the FPLC fractions, Western
blotting was performed using serum of rabbits immunized with the
purified rat
-lyase/GTK. Rabbit antiserum raised against highly purified rat renal
-lyase/GTK was kindly provided by Dr. A. Yamauchi (Kobe University, Japan). A very strong cross-reactivity, with
a mass identical with to of the purified
-lyase/GTK, was observed in
fraction 10. Of all other fractions, only a weak staining was observed
in fraction 11 (data not shown). Fractions 12 to 18, which showed
significant
-elimination activity and KMB consumption, apparently
did not contain the
-lyase/GTK protein at all.
Activity of aspartate aminotransferase was present only in fractions 8 and 9, with a 5-fold higher activity in fraction 8 (data not shown).
The fact that fraction 8 does not show
-elimination activity
indicates that aspartate aminotransferase is not involved in the
-elimination activity of the conjugates studied.
Fractionation of Rat Kidney Cytosol by Gel Filtration
Chromatography.
Rat renal cytosol was also fractionated by
high-resolution gel filtration chromatography using a HiLoad 16/60
Superdex 200 column. By using
Se-(4-methylbenzyl)-L-selenocysteine and CTFE-Cys as
substrates, activity profiles were determined. As shown in Fig.
4, at least two broad peaks with
-elimination activity were shown. For both substrates, maximal
activity was present in fraction 20, which eluted 150 min after the
application of renal cytosol to the column. According to the
calibration by the marker protein mixture, the mass of this protein
will be around Mr 300,000. The second
peak had its highest activity in fraction 37, which eluted after 167 min. According to the calibration by the marker protein mixture, the
mass of this protein will between Mr
66,000 and 132,000, which may be consistent with the 90-kDa
-lyase
protein or proteins.
|
| |
Discussion |
|---|
|
|
|---|
Local activation of cysteine S-conjugates by renal
-eliminating enzymes has been proposed as a novel approach to target
antitumor compounds 6-mercaptopurine and 6-thioguanine to the kidney
(Hwang and Elfarra, 1989
, 1991
). More recently, selenocysteine
Se-conjugates were proposed as alternative kidney-selective prodrugs
showing much higher
-elimination activities in rat renal cytosol
than their corresponding sulfur analogs (Andreadou et al., 1996
).
However, as yet little is known regarding which proteins are actually
involved in the
-elimination reactions of these S- and
Se-conjugates because activities have been measured only in crude
enzyme fractions such as kidney homogenates, mitochondria, and cytosols.
One of the enzymes capable of catalyzing transamination and
-elimination reactions is
-lyase/GTK. It has been suggested that
large noncharged amino acids are transaminated by
-lyase/GTK (Cooper
and Meister, 1974
). Using purified
-lyase/GTK from rat kidney, next
to transamination, a high
-elimination activity has been
demonstrated with 1,2-DCV-Cys and TFE-Cys as substrates. No
-elimination activity was observed using
S-(benzothiazolyl)-L-cysteine (BTC)
(Yamauchi et al., 1993
), 5'-S-cysteinyldopamine and
leukotriene E4 as substrates (Abraham et al.,
1995
). In the present study, nine additional cysteine
S-conjugates were evaluated as substrates for purified renal
-lyase/GTK. As shown in Table 1, high
-elimination activities
were also observed with CTFE-Cys and DCDFE-Cys as substrate. In
accordance with the observations by Stevens et al. (1986)
using 1,2-DCV-Cys, significant transaminase activity was also observed as
implicated by the relatively high rates of KMB consumption that were observed.
The present study confirms that cysteine S-conjugates
carrying nonhalogenated substituents are poor substrates in comparison with their selenium analogs (Table 1). Enzymatic pyruvic acid production was only 25 to 50% of the low nonenzymatic degradation of
the conjugates (data not shown). Only at a higher enzyme concentration and with a longer incubation time was significant consumption of KMB
observed for these S-conjugates, indicative of a preference for transamination reactions. Although the present nonhalogenated cysteine S-conjugates have not yet been tested with the
purified rat
-lyase/GTK, some of them have been tested previously as
substrates for purified
-lyases from bovine and turkey kidney
(Bhattacharya and Schultze, 1967
). Consistent with the present study,
no
-elimination was previously observed with
S-methyl-L-cysteine,
S-ethyl-L-cysteine, S-propyl-L-cysteine,
S-benzyl-L-cysteine, and
S-allyl-L-cysteine. Lash et al. (1990)
reported that BTC and
S-(benzothiazolyl)-L-homocysteine were
actively
-eliminated by a purified
-lyase from human kidney. However, Yamauchi et al. (1993)
did not find any activity of purified rat renal
-lyase/GTK toward BTC, suggesting a significant species difference in substrate selectivity between the human and rat enzymes.
This species difference is further supported by the overall 18%
dissimilarity between the amino acid sequences of the rat and human
enzyme (Perry et al., 1993
).
Selenocysteine Se-conjugates previously were shown to be
-eliminated
at a high activity by renal cytosol (Andreadou et al., 1996
). The
results of the present study suggest that
-lyase/GTK plays a major
role in this reaction, because most Se-conjugates were
-eliminated
at a very high activity. Several selenocysteine Se-conjugates displayed
-elimination activities as high as that observed with TFE-Cys, which
was the best substrate known. As was observed previously in rat renal
cytosol, the activity of
-elimination of Se-conjugates was much
higher than
-elimination of corresponding S-conjugates
(Table 1). Possible explanations for the higher
-elimination
reactions of selenocysteine Se-conjugates may be the weaker bond
strength of the C-Se-bond (234 kJ/mol) versus C-S-bonds (272 kJ/mol) (Guziec, 1987
) and/or a more facilitated
-proton abstraction
of the selenocysteine moiety (Miles, 1986
). As indicated by the
significant KMB consumption, transamination reaction is a prominent
pathway of biotransformation of both selenocysteine Se-conjugates and
cysteine S-conjugates. When comparing specific activities of
transamination, selenocysteine Se-conjugates as substrates showed 5- to
10-fold higher activities compared with their sulfur analogs (Table 1).
Because transamination reactions do not involve C-Se-scission,
facilitation of
-proton abstraction by electronic effects of the Se
atom may be the most likely explanation.
Because only very few substrates have been identified as yet, little
was known regarding the structure-activity relationship of
-lyase/GTK-catalyzed
-elimination reactions. Because of their surprisingly high activities, the class of selenocysteine Se-conjugates may be interesting probe substrates to characterize the
substrate-binding site. For the alkyl-substituted Se-conjugates, an
increase in the alkyl-chain appears to increase the affinity for the
enzyme, as indicated by the decrease in their
Km value (Table 1). The benzyl-substituted Se-conjugates appeared to be extremely good substrates as well, especially when substituted at the
para-position of the benzyl group. No clear electronic
effects were observed because both electron-withdrawing and
electron-donating para-substituents appeared to increase
-elimination activity compared with
Se-benzyl-L-selenocysteine. Therefore, apparently
steric properties or lipophilicity plays a more important role.
Surprisingly, the introduction of para-substituents in
Se-phenyl-L-selenocysteine led to a very strong
decrease in enzyme activities (Table 1).
When comparing enzyme kinetic parameters of the purified
-lyase/GTK
with those obtained previously with rat renal cytosol, a very poor
correlation is found. The most striking difference is found with the
para-substituted
Se-phenyl-L-selenocysteine compounds, which
showed high activity with rat renal cytosol (Andreadou et al., 1996
)
but demonstrated only a minor activity with purified
-lyase/GTK. By
determining the activity profile in fractionated rat renal cytosol, the
present study reveals that the poor correlation between cytosolic and
purified enzyme activities may be explained by the involvement of
multiple enzymes in the cytosolic fractions (Figs. 3 and 4). Aspartate
aminotransferase, which was proposed by Kato et al. (1996)
as an
alternative rat renal
-lyase enzyme, does not appear to be involved
in
-elimination of the conjugates tested. According to the results
of the gel filtration chromatography, an important role may be played
by the high-molecular-weight
-lyase previously characterized by
Abraham et al. (1995)
.
Recently, it was shown that selenium-enriched garlic was more effective
in cancer prevention than normally grown garlic (Lu et al., 1996
).
Among the selenium species identified in selenium-enriched garlic were
two of the selenocysteine Se-conjugates,
Se-methyl-L-selenocysteine and
Se-allyl-L-selenocysteine, tested in this study. Dietary
administration of these selenocysteine Se-conjugates to rats indeed
provided strong protection against methylnitrosourea-induced
carcinogenesis in rats (Ip et al., 1999
). Chemopreventive activities of
these selenocysteine Se-conjugates have been attributed to methyl
selenol (Ip and Ganther, 1992
) and diallyl selenide (Lu et al., 1996
), respectively, both of which are formed via
-elimination reactions. The relatively high activity of purified
-lyase/GTK toward these selenocysteine Se-conjugates (Table 1) may implicate a role of
-lyase/GTK in the chemopreventive activity of selenium-enriched garlic. Diallyl selenide was reported to have a 100-fold higher chemopreventive activity than diallyl sulfide, which is an important chemopreventive agent in normally grown garlic (el-Bayoumy et al.,
1996
). Therefore, the combination of higher bioactivation activity with
formation of a 100-fold more potent product may explain the higher
chemopreventive activity of Se-allyl-L-selenocysteine compared with S-allyl-L-cysteine.
In conclusion, the results presented here indicate that rat renal
-lyase/GTK plays an important role in the
-elimination of
selenocysteine Se-conjugates by rat renal cytosol. The high
-elimination activity in combination with the potent antitumor activities of the formed selenol compounds makes selenocysteine Se-conjugates promising prodrugs to treat renal cell carcinoma. Fractionation of renal cytosol by two different types of
chromatography, however, revealed that next to
-lyase/GTK,
additional enzymes are active in the
-elimination of selenocysteine
Se-conjugates. The identity and tissue distribution of these additional
enzymes remain to be established to predict the kidney selectivity of selenocysteine Se-conjugates as prodrugs.
| |
Acknowledgments |
|---|
Dr. S. Jespersen (TNO Nutrition and Food Research) at the
Department of Bio-Pharmaceutical Analysis (Zeist, the Netherlands) is
gratefully acknowledged for performing the MALDI-TOF mass spectrometry measurements on
-lyase/GTK.
| |
Footnotes |
|---|
Accepted for publication April 19, 2000.
Received for publication January 6, 2000.
1 Financial support was provided by the European Science Foundation.
2 I.A. was a visiting scientist from School of Pharmacy of the Aristotelian University of Thessaloniki, Greece.
3
Due to a typing error, Abraham and Cooper (1996)
originally reported a mass of Mr 45,800 for
this protein. The correct mass of the protein, based on its cDNA
sequence, is Mr 48,500 (D. G. Abraham,
personnel communication).
4
MALDI-TOF mass spectrometry measurements were
carried out on a VISION 2000 (Finnigan MAT, Bremen, Germany) (for
details, see Jespersen et al., 1995
). Samples containing 125 fmol of
-lyase/GTK in 2,5-dihydroxybenzoic acid as matrix were
irradiated with a nitrogen laser at 337 nm. Mass spectra were
accumulated for 25 laser shots fired at the same spot on the sample surface.
Send reprint requests to: Dr. Jan N. M. Commandeur, Leiden/Amsterdam Center for Drug Research (LACDR), Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, the Netherlands. E-mail: command{at}chem.vu.nl
| |
Abbreviations |
|---|
GSH, glutathione;
-lyase, cysteine
S-conjugate
-lyase;
GTK, glutamine transaminase K;
KMB,
-keto-
-methiolbutyric acid;
OPD, o-phenylene
diamine;
FPLC, fast protein liquid chromatography;
BTC, S-(benzothiazolyl)-L-cysteine;
1,2-DCV-Cys, S-(1,2-dichlorovinyl)-L-cysteine;
TFE-Cys, S-(1,1,2,2-tetrafluoroethyl)-L-cysteine;
PMSF, phenylmethylsulfonyl fluoride;
CTFE-Cys, S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine;
DCDFE-Cys, S-(2,2-dichloro-1,1-difluoroethyl)-L-cysteine;
MALDI-TOF, matrix-assisted laser desorption time-of-flight.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. J. L. Cooper, I. R. Younis, Z. V. Niatsetskaya, B. F. Krasnikov, J. T. Pinto, W. P. Petros, and P. S. Callery Metabolism of the Cysteine S-Conjugate of Busulfan Involves a {beta}-Lyase Reaction Drug Metab. Dispos., August 1, 2008; 36(8): 1546 - 1552. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rossi, Q. Han, J. Li, J. Li, and M. Rizzi Crystal Structure of Human Kynurenine Aminotransferase I J. Biol. Chem., November 26, 2004; 279(48): 50214 - 50220. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rooseboom, J. N. M. Commandeur, and N. P. E. Vermeulen Enzyme-Catalyzed Activation of Anticancer Prodrugs Pharmacol. Rev., March 1, 2004; 56(1): 53 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rooseboom, G. Schaaf, J. N. M. Commandeur, N. P. E. Vermeulen, and J. Fink-Gremmels beta -Lyase-Dependent Attenuation of Cisplatin-Mediated Toxicity by Selenocysteine Se-Conjugates in Renal Tubular Cell Lines J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 884 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rooseboom, N. P. E. Vermeulen, I. Andreadou, and J. N. M. Commandeur Evaluation of the Kinetics of beta -Elimination Reactions of Selenocysteine Se-Conjugates in Human Renal Cytosol: Possible Implications for the Use as Kidney Selective Prodrugs J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 762 - 769. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||